Danske Bank predicts bumps ahead for Ambu despite strong start to financial year
Medical device company Ambu outperformed expectations on all financial metrics in the first quarter. According to Danish bank Danske Bank, the lack of an upward revision means that an upgrade in expectations is more likely to land in the second quarter of 2023/24, say analysts Christian Ryom and Thomas Bowers following Ambu’s first-quarter report on Tuesday.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Ambu CEO open to acquisitions: "We are looking into it now"
For subscribers
Analysts: Ambu could be poised for an upward revision
For subscribers